High dose-rate brachytherapy boost for intermediate risk prostate cancer: Long-term outcomes of two different treatment schedules and early biochemical predictors of success.

By: admin | Tags:

HDR boost with single fraction 15 Gy provides durable long-term biochemical disease-free survival. PSA nadir <0.4 ng/ml is associated with very low risk of biochemical failure.

CT-guided brachytherapy as salvage therapy for intrahepatic recurrence of HCC after surgical resection

By: admin | Tags:

Perioperative Interstitial High-Dose-Rate Brachytherapy for the Treatment of Recurrent Keloids: Feasibility and Early Results

By: admin | Tags: brachytherapy, keloid

Comparison of High-Dose-Rate Endorectal Brachytherapy versus Conventional Chemoradiotherapy

By: admin | Tags:

Comparison of High-Dose-Rate Endorectal Brachytherapy versus Conventional Chemoradiotherapy in the Neoadjuvant Setting for Low Rectal Cancer International Journal of Surgical Oncology Volume 2012 (2012)